• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Make the most of predictive analytics: Top tips for health systems, health plans


Predictive analytics involves extracting information from data and using it to forecast the future based on existing patterns and associations. For managed care organizations, the potential is limitless.

Predictive analytics involves extracting information from data and using it to forecast the future based on existing patterns and associations. It has been used to optimize existing processes, better understand customer behavior, identify unexpected opportunities, and anticipate problems before they happen. For managed care organizations, the potential is limitless.  


Kelley“By pooling all data resources, health insurers can look at a population’s risk factors and make all types of predictions, such as what diseases patients are most likely at risk for in the future,” says Kristen Kelley, MPH, CIC, CLC, director, Infection Prevention, Indiana University Health, the largest healthcare system in Indiana.

As the senior vice president of Healthcare Analytics at Indianapolis, Indiana-based Anthem, Inc., Patrick McIntyre sees significant opportunities to better leverage big data to support optimal decision making. “Payers have historically only used claims data for predictive analytic models to help better guide members’ care,” he says. “However, with technological advances, we can better leverage clinical data (i.e., EHRs, laboratory results, etc.) as well as psycho-socioeconomic data to predict members’ healthcare needs.”

To capitalize on these emerging capabilities, Anthem has launched “member clinical risk modeling.” It applies data science techniques and tools, such as machine learning and pattern recognition analytics, to improve clinical risk assessment results through more precise clinical models. “These new models, when implemented in a big data environment, offer the ability to develop and score predictive analytic models in a matter of minutes rather than weeks,” McIntyre says. “Combining new models with big data capabilities has resulted in more timely and precise clinical models that we now use for our plans to achieve a more proactive and targeted outreach to assist members in making healthcare decisions.”


For example, when a member diagnosed as diabetic hasn’t been filling his prescriptions for insulin or other medications Anthem health plans have this information in their claims data. “We can analyze that data and share the information with the member’s primary care physician to alert them of a potential risk,” McIntyre says. “That physician now has the opportunity to directly contact that member, and perhaps prevent an emergency medical event that could lead to a costly hospitalization or emergency room visit.”

In addition, Anthem has been leveraging big data to help law enforcement and federal agencies recoup tens of millions of dollars lost to fraud, waste, and abuse (FWA). These FWA recovery efforts are projected to grow into the hundreds of millions of dollars over the next several years. In 2016, Anthem implemented real-time analytics leveraging big data tools and techniques to detect potential FWA claims before payments were made, which accelerated its investigative activities.


Richard Clarke, PhD, vice president of advanced analytics and reporting, Highmark Health, Pittsburgh, believes that the most valuable analytics lead to differential business decisions that deliver more value to members. “As an industry, healthcare is data rich, but often insight poor,” he says. “Highmark is focused on ensuring that its analytics (both standard reporting and advanced predictive/prescriptive models) are connected to and integrated with our business processes. We are seeing examples in which tangible value is delivered through advanced analytical techniques that leverage new and diverse data sources. This could be incorporating social determinant data to better predict what intervention will deliver the most impact for a member, blending clinical and claims data to prescribe the best transition of care plans, or predicting which member is most likely to have an avoidable emergency room visit in the near future.”

Health systems


In the past decade, health systems have made a major push to get a handle on their clinical data. “As the Affordable Care Act fostered risk-based arrangements, health systems have increasingly developed the necessary resources to better understand their populations’ needs and issues,” says Adam C. Powell, PhD, president, Payer+Provider Syndicate, an operational and strategic healthcare consulting company.

The Healthcare Information and Management Systems Society’s Electronic Medical Record Adoption Model suggests that many health systems now have relatively mature EHRs. “By having more comprehensive data, they can make more accurate predictions,” Powell says. “We have had recent advances in interinstitutional data sharing, which is increasingly enabling providers to incorporate externally-generated clinical data into their models.”


Despite these advances, Bill Fox, JD, MA, vice president, healthcare and life sciences, MarkLogic, a data integration platform, says the pressure is on health systems to make analytics more actionable. “We are at a stage in which payers, providers, and hospital systems-and even different areas within those systems-might each use different purpose-specific data to meet their unique requirements,” he says.

For instance, one data warehouse may drive cardiac disease management and another warehouse may drive diabetes management, creating two unnecessary silos and a costly and time-consuming project to integrate them, despite the fact that these conditions are often seen together in comorbidity populations. “The end result has been an exponential growth of data silos that create real data governance challenges and undermine the return on investment of predictive analytics solutions,” Fox says. “Health systems can reduce these governance issues and gain more value from their analytics solutions by implementing operational data hubs. Within these hubs, all data reside in one place and can be leveraged for both analytic and operational purposes, thereby improving data integrity, security, and data management challenges-while allowing information to be leveraged more cost effectively across hospital systems and departments.”

Next: Health plans



Health plans

Health insurers continue to use their claims data to build predictive models. Because claims have been processed digitally for years, health plans often have more mature predictive analytics capabilities than health systems, Powell says. Furthermore, insurers’ larger size gives them the necessary scale to afford investments in analytics.

But despite what has been accomplished, there is much more to do. “The healthcare industry is very early in its journey of employing predictive analytics,” Clarke says. “The potential is immense, but turning that potential into tangible business value has not been proven at scale. This is partly due to the technical challenge of having data that are large and complicated; true data experts are often not facile with new approaches and techniques to turn data into insights. However, an even bigger challenge to adoption is proving impact. Many of the most exciting use cases involve long-term changes in care patterns that make it difficult to prove impact. Therefore, there’s a great focus on revenue capture and other areas where the direct link to impact is clearer.”  

McIntyre says that many health insurers have recognized that claims-based analytics alone are insufficient to fully optimize the quality and affordability of healthcare. As a result, many payers have invested in advanced analytics capabilities that leverage claim, clinical, and nonclaim/nonclinical data wherever possible. “Many larger payers are building these capabilities internally, while others are leveraging healthcare analytics vendors in the marketplace,” he says. “Progress in leveraging claim-based analytics is generally well developed with most payers and/or healthcare analytics vendors. However, only in recent years has much traction been made at integrating clinical and psycho-socioeconomic data in a meaningful way.

Again, using the example of a member diagnosed with diabetes, Anthem can use the member’s digital interactions with an Anthem health plan along with medical records information from a provider partner to analyze the member’s body weight, demographics, physical activity, and other information to help make the connection to a treatment or wellness plan that may not be as invasive or expensive for the patient. “Perhaps it’s providing them with information about healthy nutrition for people with diabetes, or sharing information about physical fitness or directing them to a nutritionist. We can work to find the easiest and least-expensive option,” McIntyre says.

McIntyre says this is where the majority of capital investments by payers will occur over the next several years. This will require a combination of attracting the right talent, such as experts in big data and data science, and investing time and resources to build new value-based relationships with providers and engage with consumers in a way that payers have not done in the past.

Common barriers


As far as specific gaps, Vijay Murugappan, vice president, analytics and process transformation, Health Care Service Corporation, a customer-owned health insurer in Chicago, says typical lags in predictive analytics occur when the volume and granularity of coverage data (across members or conditions, for example) are not enough to derive and accept data-driven insight. For example, laboratory and pharmacy data provide good insights for obtainable data, but because such data is not available for most or all of a population, applying these insights broadly can be tricky.

For independent general practitioners, Fox says the benefits of analytics are effectively out of reach due to cost. “The smaller the entity, the more this is true,” he says. “With a single patient’s information being spread over disparate systems-customer relationship management, billing management, and EHRs-smaller providers experience the same obstacles presented by data in silos, but they lack the scale to readily deploy cost-effective data management and analytics solutions. Instead, valuable patient information sits unused and sometimes even abandoned in documents, content management systems, and even worse-in filing cabinets and boxes. The result of this stark reality is that the lack of access to essential technologies is driving consolidation among these smaller provider entities that need to compete in this era of outcomes-based reimbursement, which could potentially benefit patients.”


Marshall Greene, analytics manager, Mosaic Medical, a community healthcare organization with clinics across Central Oregon, says one challenge in predicting health outcomes is that the timeline for realizing a return on investment can be quite long. For instance, in trying to predict a patient’s claims costs, forgoing preventative care and screenings may lead to lower costs in the short and even medium term. However, if it means that a chronic condition goes unmanaged or cancer goes undiagnosed, the short-term savings turn into a very expensive patient decades later.

Improvement goals

Healthcare organizations frequently struggle to operationalize the clinical insights gleaned from predictive analytics for a couple of reasons, Greene says. First, there is an inherent disconnect between the analysts/data scientists who create the predictive models and practitioners who need to use the information to guide an intervention. “Analysts generally don’t have a formal clinical background and often have very little context for the disease pathways and health outcomes that they are trying to predict,” he says. “Hence, once the analytics team has developed a model that they think can bring value to an organization, they don’t have the clinical background to make a strong recommendation as to what an appropriate clinical intervention would be.”

On the other side of the fence, clinicians have been trained to treat the patient in the exam room. “Thinking about how to actively engage an at-risk population prior to a problem occurring is a big paradigm shift for a provider-one that many analytical organizations like Mosaic Medical are still grappling with,” Greene says.

In addition, trying to incorporate new work flows-especially ones based on predictive models that have an inherent level of uncertainty-is difficult in any industry. “At a time when many providers are being asked to see more patients, add relative value units, and check more boxes to meet quality measures, it is hard for clinicians to find time to think strategically, let alone collaborate on predictive model development,” Greene says. “If the analytics team works in silos without frequent input from practitioners, their predictive clinical efforts are bound to fail.”


Donald Fry, MD, executive vice president, Clinical Outcomes Management at MPA Healthcare Solutions, an analytic healthcare consultancy, says that hospitals generally do not have internally risk-adjusted outcomes or cost evaluations of specific clinical services because it is too expensive. In addition, the interpretation of risk-adjusted outcomes needs to be benchmarked to a national or regional level of performance. “Hospitals find little value in conducting risk-adjusted outcomes without a reference group to gauge performance,” he says. “State or regionally based programs of risk-adjusted outcomes use comparative effectiveness and efficiency evaluations of hospitals so that common reporting and common evaluation metrics can be used to drive improvement. Insurers could be key players in the development of state-wide databases.”


Karen Appold is a medical writer in Lehigh Valley, Pennsylvania.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.